Pelvic Examination in Pregnancy
PEP
Utility of Pelvic Examination in the Evaluation of Threatened Abortion
1 other identifier
interventional
220
1 country
1
Brief Summary
This study is designed to determine whether the pelvic examination (including bimanual and speculum examination) is necessary in patients with first trimester vaginal bleeding/ lower abdominal pain when an intra-uterine pregnancy (IUP) is seen on ultrasound. Patients with the chief complaint of vaginal bleeding or lower abdominal pain less than 16 weeks and positive HCG will be considered for this non-inferiority-designed clinical trial. All patients who present to the BMC Emergency Department (ED) Mon - Fri from 8am to 11pm and have had serum or urine HCG testing and a formal ultrasound by a credentialed emergency physician or radiology technician as part of standard of care will be screened for further eligibility. Those patients with intra-uterine pregnancies \< 16 weeks gestation seen on ultrasound and meet inclusion criteria will then be asked to provide informed consent to participate in the study. Randomization will occur after consent has been obtained. Half of the patients will be randomized to receive pelvic examinations and the other half will not. Further care will be determined by the treating attending physician. The primary outcome will be a composite morbidity endpoint at 30 days, including return visits to the ED, emergency surgery, need for transfusion, infection, or other missed source of bleeding/ pain. Secondary outcomes of interest include ED throughput time, and patient satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 27, 2012
CompletedFirst Posted
Study publicly available on registry
April 4, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedMay 4, 2017
May 1, 2017
3.9 years
February 27, 2012
May 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Composite Morbidity Endpoint
Adverse events include, but are not limited to, return visits to the Emergency Department, need for hospital admission, emergency procedure, transfusion, infection, or identification of other source of symptoms.
30 Days
Secondary Outcomes (2)
Patient Satisfaction
24 Hours
Throughput Time
24 Hours
Study Arms (2)
Pelvic Exam
ACTIVE COMPARATORSubjects receive pelvic exam
No Pelvic Exam
EXPERIMENTALSubjects do not receive pelvic exam
Interventions
Eligibility Criteria
You may qualify if:
- Chief complaint of vaginal bleeding or lower abdominal pain
- Intra-uterine pregnancy seen on ultrasound
- Date \< 16 weeks by estimated LMP or ultrasound
- Age \>21
- Ability to provide written informed consent
- English speaking
You may not qualify if:
- Already enrolled in study
- Morbid Obesity (BMI \> 40)
- Pelvic exam performed prior to ultrasound results
- Prisoner
- Follow up cannot be assured
- Admitted to hospital
- Large amount of vaginal bleeding (\>10 pads in 24 hours or equivalent)
- Unstable vital signs (SBP\<90 or HR\>110)
- Known cervical carcinoma in the past 1 year
- Clinical suspicion for alternative syndrome that requires pelvic exam (such as severe pain consistent with ovarian torsion)
- Report or suspicion of penetrating vaginal trauma
- Suspicion of Active Labor
- Reported Sexual Assault
- Current pregnancy by IVF
- IUD in place
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, United States
Related Publications (5)
Brown J, Fleming R, Aristzabel J, Gishta R. Does pelvic exam in the emergency department add useful information? West J Emerg Med. 2011 May;12(2):208-12.
PMID: 21691528BACKGROUNDBrown T, Herbert ME. Medical myth: Bimanual pelvic examination is a reliable decision aid in the investigation of acute abdominal pain or vaginal bleeding. CJEM. 2003 Mar;5(2):120-2. doi: 10.1017/s1481803500008289.
PMID: 17475104BACKGROUNDHoey R, Allan K. Does speculum examination have a role in assessing bleeding in early pregnancy? Emerg Med J. 2004 Jul;21(4):461-3. doi: 10.1136/emj.2003.012443.
PMID: 15208231BACKGROUNDIsoardi K. Review article: the use of pelvic examination within the emergency department in the assessment of early pregnancy bleeding. Emerg Med Australas. 2009 Dec;21(6):440-8. doi: 10.1111/j.1742-6723.2009.01227.x.
PMID: 20002713BACKGROUNDSeymour A, Abebe H, Pavlik D, Sacchetti A. Pelvic examination is unnecessary in pregnant patients with a normal bedside ultrasound. Am J Emerg Med. 2010 Feb;28(2):213-6. doi: 10.1016/j.ajem.2008.10.018.
PMID: 20159393BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith Linden, MD
Boston Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- BMC Faculty
Study Record Dates
First Submitted
February 27, 2012
First Posted
April 4, 2012
Study Start
February 1, 2012
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
May 4, 2017
Record last verified: 2017-05